Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS) -- Ignore unavailable to you. Want to Upgrade?

To: Sigmund who wrote (641)	5/21/1998 12:47:00 PM
From: Damon Pham	Read Replies (1) \| Respond to of 849

Sigmund, You're right in your thinking. FDA process is a two-way street. Companies pay the FDA for the cost of evaluating their products/drugs. It is very much a collabrative effort. Someone involved in their application must have signaled that they had a chance for approval. However, the company should have stayed on top of it due to its potential impact (both good and bad--which we all found out too well). Lots of support in Congress for reforms at the FDA. It should help, but lets not kid ourselves. Anything involving the government takes a long, long time to implement. Committee this, committe that....